Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Bishop

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Surgical Laparoscopy & Endoscopy|April 1, 1993
Laparoscopic Doderlein hysterectomy: a rational alternative to traditional abdominal hysterectomyW B Saye, G B Espy, M R Bishop, et al.
Bone Marrow Transplantation|October 21, 2000
Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantationT J Stinson, J R Adams, M R Bishop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical OncologyC L Bennett, M R Bishop, M S Tallman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphomaP J Bierman, J M Vose, J R Anderson, et al.
Experimental Hematology|May 20, 1998
Depletion of EBV-infected cells in donor marrow by counterflow elutriationT G Gross, S H Hinrichs, J R Davis, et al.
Leukemia & Lymphoma|March 18, 2000
Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision makingC L Bennett, T J Stinson, J H Laver, et al.
Journal of Toxicology. Clinical Toxicology|August 10, 2000
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatmentJ E Mata, M R Bishop, S R Tarantolo, et al.
Blood|September 6, 2001
Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristicsS S Joshi, J C Lynch, S Z Pavletic, et al.
Cytotherapy|April 30, 2010
Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating techniqueS J Pirruccello, C J Page, M R Bishop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapyP J Bierman, J R Anderson, M B Freeman, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Surgical Laparoscopy & Endoscopy|April 1, 1993
Laparoscopic Doderlein hysterectomy: a rational alternative to traditional abdominal hysterectomyW B Saye, G B Espy, M R Bishop, et al.
Bone Marrow Transplantation|October 21, 2000
Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantationT J Stinson, J R Adams, M R Bishop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical OncologyC L Bennett, M R Bishop, M S Tallman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphomaP J Bierman, J M Vose, J R Anderson, et al.
Experimental Hematology|May 20, 1998
Depletion of EBV-infected cells in donor marrow by counterflow elutriationT G Gross, S H Hinrichs, J R Davis, et al.
Leukemia & Lymphoma|March 18, 2000
Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision makingC L Bennett, T J Stinson, J H Laver, et al.
Journal of Toxicology. Clinical Toxicology|August 10, 2000
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatmentJ E Mata, M R Bishop, S R Tarantolo, et al.
Blood|September 6, 2001
Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristicsS S Joshi, J C Lynch, S Z Pavletic, et al.
Cytotherapy|April 30, 2010
Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating techniqueS J Pirruccello, C J Page, M R Bishop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapyP J Bierman, J R Anderson, M B Freeman, et al.
Pageof 8